Related Experiment Video
Updated: Jan 24, 2026

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
Prediction of Clinical Safety for High-Dose Methotrexate Chemotherapy Based on Free Levels of Methotrexate and
Shuai-Shuai Gao1, Chun-Ling Wu1, Yi Liu1
1Department of Pharmacy, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Background:
High-dose methotrexate is widely used in chemotherapy for malignant tumors. This study explores the correlation between methotrexate (MTX) and 7-hydroxy methotrexate (7-OHMTX) concentrations and indicators of liver and kidney function while evaluating the predictive value of MTX and 7-OHMTX levels for delayed elimination.
Methods:
The authors collected 372 blood samples from 107 leukemia or lymphoma patients (45 adults and 62 children) treated with high-dose methotrexate. The free and total concentrations of MTX and 7-OHMTX were measured 48, 72, or 96 hours after chemotherapy administration. SPSS 27 software was used to analyze the Spearman correlation between concentration and liver and kidney indicators. The nonparametric Mann-Whitney U test was used to compare the Normal and Delayed groups. Receiver operating characteristic curve analysis identified the threshold for delayed elimination.
Results:
The total 7-OHMTX concentration did not correlate with creatinine clearance (CCR) and creatinine (CR) in children. The free 7-OHMTX concentration showed a significant negative correlation with CCR (P < 0.01) and a positive correlation with CR (P < 0.01) in children and in subgroup A2 (7-12 years). Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were significantly negatively correlated with both total and free 7-OHMTX/MTX concentrations in children (P < 0.01). MTX and 7-OHMTX concentrations showed no correlation with CR, CCR, AST, or ALT in adult patients.
Conclusions:
Clinicians should closely monitor patients for signs of elimination delay when free 7-OHMTX concentrations exceed 0.081 μmol/L 48 hours or later. Incorporating free-concentration monitoring predicts hepatotoxicity and nephrotoxicity in children more accurately than total concentrations alone, facilitating timely clinical intervention and ensuring patient safety.
Related Concept Videos
Survey Safety
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
Leveling Effect and Non-Aqueous Acid-Base Solutions
The Leveling Effect of a Solvent
A generic acid (HA) reacts with the generic base (B-) to yield the corresponding conjugate base (A-) and conjugate acid (HB):
Predicting Molecular Geometry
Dose Size and Dosing Frequency: Determination Methods

